{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:33:57Z","timestamp":1773308037930,"version":"3.50.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T00:00:00Z","timestamp":1387497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0084026","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T16:52:00Z","timestamp":1387558320000},"page":"e84026","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["Interferon-\u03bb4 (IFNL4) Transcript Expression in Human Liver Tissue Samples"],"prefix":"10.1371","volume":"8","author":[{"given":"Ahmad","family":"Amanzada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waltraut","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Spengler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliano","family":"Ramadori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Mihm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,12,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharmthera.2012.03.006","article-title":"Pharmacology and therapeutic potential of interferons","volume":"135","author":"PM George","year":"2012","journal-title":"Pharmacol Ther"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"P Sheppard","year":"2003","journal-title":"Nat Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"SV Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/hep.21312","article-title":"Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes","volume":"44","author":"SE Doyle","year":"2006","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/hep.23743","article-title":"Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection","volume":"52","author":"AJ Muir","year":"2010","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1128\/JVI.75.3.1332-1338.2001","article-title":"Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization","volume":"75","author":"R Patzwahl","year":"2001","journal-title":"J Virol"},{"key":"ref7","first-page":"1148","article-title":"Interferon type I gene expression in chronic hepatitis C. Lab Invest","volume":"84","author":"S Mihm","year":"2004"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9440(10)64884-5","article-title":"Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression","volume":"160","author":"NA Shackel","year":"2002","journal-title":"Am J Pathol"},{"key":"ref9","first-page":"3939","article-title":"Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method","volume":"62","author":"N Iizuka","year":"2002","journal-title":"Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3390\/v1031073","article-title":"HCV innate immune responses","volume":"1","author":"MH Heim","year":"2009","journal-title":"Viruses"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"DL Thomas","year":"2009","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"D Ge","year":"2009","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"V Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Y Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1073\/pnas.0707882105","article-title":"Interferon signaling and treatment outcome in chronic hepatitis C","volume":"105","author":"M Sarasin-Filipowicz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/hep.21853","article-title":"Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response","volume":"46","author":"JJ Feld","year":"2007","journal-title":"Hepatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.gastro.2010.04.049","article-title":"Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C","volume":"139","author":"M Honda","year":"2010","journal-title":"Gastroenterology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/hep.23912","article-title":"IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C","volume":"52","author":"TJ Urban","year":"2010","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1053\/j.gastro.2010.11.039","article-title":"Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.","volume":"140","author":"MT Dill","year":"2011","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hep.24623","article-title":"Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response","volume":"55","author":"Y Asahina","year":"2012","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"L Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.20130012","article-title":"IL28B expression depends on a novel TT\/-G polymorphism which improves HCV clearance prediction","volume":"210","author":"S Bibert","year":"2013","journal-title":"J Exp Med"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Aka PV, Kuniholm MH, Pfeiffer RM, Wang AS, Tang W, <etal>et al<\/etal>.. (2013) Association of the IFNL4-DeltaG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus. J Infect Dis. doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1093\/infdis\/jit433\" xlink:type=\"simple\">10.1093\/infdis\/jit433<\/ext-link>","DOI":"10.1093\/infdis\/jit433"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1046\/j.1537-2995.2001.41091100.x","article-title":"A novel RT-PCR for reliable and rapid HCV RNA screening of blood donations","volume":"41","author":"H Hennig","year":"2001","journal-title":"Transfusion"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000339879","article-title":"High predictability of a sustained virological response (87%) in chronic hepatitis C virus genotype 1 infection treatment by combined IL28B genotype analysis and gamma-glutamyltransferase\/alanine aminotransferase ratio: a retrospective single-center study","volume":"86","author":"A Amanzada","year":"2012","journal-title":"Digestion"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/1471-2105-8-428","article-title":"Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool &apos;CubeX&apos;","volume":"8","author":"TR Gaunt","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/hep.25647","article-title":"Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response","volume":"56","author":"S Naggie","year":"2012","journal-title":"Hepatology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2009.11.011","article-title":"Distinct antiviral signaling pathways in primary human hepatocytes and their differential disruption by HCV NS3 protease","volume":"52","author":"L Jouan","year":"2010","journal-title":"J Hepatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1128\/JVI.75.15.7059-7066.2001","article-title":"DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection","volume":"75","author":"CB Bigger","year":"2001","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1073\/pnas.202608199","article-title":"Genomic analysis of the host response to hepatitis C virus infection","volume":"99","author":"AI Su","year":"2002","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0084026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T23:08:10Z","timestamp":1540249690000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0084026"}},"subtitle":[],"editor":[{"given":"Golo","family":"Ahlenstiel","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,20]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0084026","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,20]]}}}